Use of nitroderivatives in urinary incontinence

Details Use of nitroderivatives in urinary incontinence Use of nitroderivatives in urinary incontinence

2004-12-22

2009-06-09

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S509000, C549S401000, C558S482000

Reexamination Certificate

active

07544711

ABSTRACT:
The present invention relates to the use of the following compounds, their compositions, and their salts for the preparation of medicaments for the treatment of urinary incontinence and other diseases, the compounds having the general formula:in-line-formulae description="In-line Formulae" end="lead"?A-X1—NO2in-line-formulae description="In-line Formulae" end="tail"?wherein:A=RCO(X)t, wherein t is the integer 0 or 1;X═O, NH, NR1C, wherein R1Cis a linear or branched C1to C10alkyl group;when t=1, R=and X1=—YO—, wherein Y is a C1to C20alkylene, C5to C7cycloalkyl or oxyalkyl derivative.

REFERENCES:
patent: 2809194 (1957-10-01), Novello et al.
patent: 2937169 (1960-05-01), Hinkley
patent: 2976289 (1961-03-01), Cohen et al.
patent: 3043840 (1962-07-01), Downing, Jr.
patent: 3055904 (1962-09-01), Graf et al.
patent: 3058882 (1962-10-01), Stürm et al.
patent: 3161654 (1964-12-01), Shen
patent: 3255241 (1966-06-01), Schultz et al.
patent: 3313848 (1967-04-01), Scherrer et al.
patent: 3360518 (1967-12-01), Shetty
patent: 3392168 (1968-07-01), Lund et al.
patent: 3415834 (1968-12-01), Hoffmann et al.
patent: 3565911 (1971-02-01), Beregi et al.
patent: 3600437 (1971-08-01), Marshall
patent: 3665002 (1972-05-01), Popelak et al.
patent: 3758506 (1973-09-01), Godfroid et al.
patent: 3784701 (1974-01-01), Tomcufcik et al.
patent: 3787440 (1974-01-01), Hamano et al.
patent: 3806534 (1974-04-01), Feit et al.
patent: 3840597 (1974-10-01), Moore et al.
patent: 3843681 (1974-10-01), Demerson et al.
patent: 3997669 (1976-12-01), Carney et al.
patent: 4018929 (1977-04-01), Delarge et al.
patent: 4035376 (1977-07-01), Janssen et al.
patent: 4954518 (1990-09-01), Takano et al.
patent: 5859053 (1999-01-01), Lesur et al.
patent: 5861426 (1999-01-01), Del Soldato et al.
patent: 6040341 (2000-03-01), Del Soldato et al.
patent: 605302 (1961-07-01), None
patent: 1149015 (1963-05-01), None
patent: 1163332 (1964-02-01), None
patent: 3834204 (1989-04-01), None
patent: 0 738 706 (1996-10-01), None
patent: 0 722 434 (1998-07-01), None
patent: 1574570 (1969-07-01), None
patent: 1195628 (1970-06-01), None
patent: 73 05 585 (1973-02-01), None
patent: 94/04484 (1994-03-01), None
patent: 94/12463 (1994-06-01), None
patent: 94/13635 (1994-06-01), None
patent: 95/15315 (1995-06-01), None
patent: 95/30641 (1995-11-01), None
patent: WO 95/30641 (1995-11-01), None
patent: 96/23786 (1996-08-01), None
patent: 97/16405 (1997-05-01), None
patent: WO 98/09948 (1998-03-01), None
patent: WO 98/09948 (1998-03-01), None
patent: WO 00/51988 (2000-09-01), None
patent: WO 00/61537 (2000-10-01), None
patent: WO 00/61537 (2000-10-01), None
patent: WO 01/12584 (2001-02-01), None
patent: WO 01/12584 (2001-02-01), None
Wallace, J. L., et al. Gastroenterology 1994, 107, 173-179.
Ward, A., et al. Drugs 1988, 36, 732-753.
Morrison, Robert Thornton, and Robert Neilson Boyd. Organic Chemistry. Boston:Allyn, 1973. pp. 591 and 603.
Savage (Medsafe, 2002), p. 1-3.
Yoshikawa et al. (JP 06206859)—Abstract (p. 1-4).
Ferguson et al., “Urinary Bladder Function and Drug Development”,Trends Pharmacol. Sci. 17, 161-165, 1996.
Anderson, “Pharmacology of Lower Urinary Tract Smooth Muscle, and Penile Erectile Tissues”,Pharmacol. Rev. 45, 253-308, 1993.
Rice, “Topical Spinal Administration of Nitric Oxide Synthase Inibitor Prevents the Hyper-Reflexia Associated with a Rat Model of Persistent Visceral Pain”,Neurosci. Lett. 187, 111-114, 1995.
Wilkinson,J. Chem. Soc. 32, 1948.
Winter et al., “Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs”,Proc. Soc. Exp. Biol. Med. 111, 544-547, 1962.
Fahry-Rd et al.,CIRC-RES. 72/6 (12020-1210) 1983.
Izumi et al., “Gestational Changes in L-arginine-induced relaxation of Pregnant Rat and Nonpregnant Myometrial Contractility”,Am. J. Obstet Gynencol. 169, 1327-1337, 1983.
Merck Index, 10thEdition, Windhoz et al. “Merck & Co.”, Rahway, N.J.
Morikawa et al., 110CA: 85899.
Persson et al., 117CA:445429, 1992.
Chung et al., 125CA:105692, 1996.
European Search Report dated Aug. 6, 2004.
Close et al., “Synthesis of Potential Diuretic Agents. I. Derivatives of 7-Sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-Dioxide”,J. Am. Chem. Soc. 82, 1132, 1960.
Del Soldato et al., “The anesthetized Guinea Pig as a Versatile Pharmacological Test Object”,J. Pharmacol. Meth. 5, 278-285, 1981.
Janes et al. “Flow Cytometric Detection of Circulating Activated Platelets and Platelet hyperresponsiveness in Pre-Eclampsia and Pregnancy”,Clin. Sci. 86, 731-739, 1994.
Dubois et al., “increased Cyclooxigenase-2 Levels in Carcinogen-Induced Rat Colonic Tumors”,Gastroenterol. 110, 1259-1262, 1996.
Zhou et al., The Inhibitory Mechanism of Nicorandil in Isolated Rat Urinary Bladder and Femoral Atrery,Eur. J. Pharmacol., 59, 153-159, 1995.
Howe et al., “ZENECA ZD 6169: A Novel KATPChannel Opener with in Vivo Selectivity for Urinary Bladder”,J. Pharmacol. Exp. Ther. 274, 884-890, 1995.
Maggi et al., “Prostanoid Modulate Reflex Micturition by Acting Through Capsaicin-Sensitive Afferents”,Eur. J. Pharmacol., 105-112, 1988.
Malmgren et al., “Custometrical Evaluation of Bladder Instability in Rats with Intraversical Obstruction”,J. Urol. 137, 1291-1294, 1987.
Werkström et al., “Factors Involved in the Relaxation of Female Pig Urethra Evoked by Electrical Field Stimulation”Br. J. Pharmacol. 116, 1599-1604, 1995.
Assreuy et al., “Feedback Inhibition of Nitric Oxide Synthase Activity by Nitric Oxide”,Br. J. Pharmacol., 833-837, 1993.
O.A. al-Swayeh et al.; “Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity”; British Journal of Pharmacology; 2000; 130; pp. 1453-1456; Macmillan Publishers Ltd.
Adrian W. Bak et al.; “Cyclooxygenase-Independent Chemoprevention With An Aspirin Derivative In a Rat Model of Colonic Adenocarcinoma”; Life Sciences; vol. 62; No. 23; 1998; pp. 367-373; Elsevier Science Inc.
Viviane Bertrand et al.; Role of tumour necrosis factor-a and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity; European Journal of Pharmacology 356; 1998; pp. 245-253; Elsevier Science B.V.
Richard J. Bing et al.; “The Pharmacology of a New Nitric Oxide Donor: B-NOD”; Biochemical and Biophysical Research Communications 275; 2000; pp. 350-353; Academic Press.
Gary L. Wenk et al.; Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons; European Journal of Pharmacology 402; 2000; pp. 77-85; Elsevier Science B.V.

Affiliated with

Also associated with

Rating

Use of nitroderivatives in urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nitroderivatives in urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nitroderivatives in urinary incontinence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080021